MAM
REGN icon

Marquette Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Marquette Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.73K Hold
14
– – ﹤0.01% 330
2026
Q1 		$10.8K Hold
14
– – ﹤0.01% 241
2025
Q4 		$10.8K Hold
14
– – ﹤0.01% 223
2025
Q3 		$7.87K Buy
+14
New +$7.92K ﹤0.01% 254

Other funds holding REGN

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Marquette Asset Management's REGN Position: Q2 2026 in Review

Marquette Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 14 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Marquette Asset Management first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.8K in Q1 2026. 683 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Marquette Asset Management held 14 shares of Regeneron Pharmaceuticals worth $8.73K as of Q2 2026.
  • Marquette Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #330 holding.
  • Marquette Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Marquette Asset Management's Regeneron Pharmaceuticals position peaked at $10.8K in Q1 2026.
  • 683 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.